Letaplimab (Anti-CD47)

Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

• Supplier: Selleck Chemicals
• Product #: A2824
• Sku #: A2824-1mg